The Council of the European Union has delivered its newest set of proposals meant to shake up European pharma regulations and sharpen its competitive edge, but the plan isn’t exactly what EU drugmakers had hoped for. More: Newly proposed EU
read moreAfter a long winter, the start of summer is ushering in some much-needed sunshine, warmer weather and, for a handful of biopharma companies, refreshed branding. More: Fujifilm, Coherus, ViGeneron unveil rebrands to better reflect ongoing work Source: fierce
read moreOrca Bio is preparing to make a splash in the cell therapy market. The biotech has hired Steve Gavel as chief commercial officer, securing itself a leader with cell therapy expertise accrued at Legend Biotech and Celgene. More: Orca hires
read moreAmneal Pharmaceuticals is recalling three lots of sulfamethoxazole/trimethoprim tablets because of microbial contamination which caused black spots to appear on the medication, according to a report from a customer. More: Amneal recalls 3 lots of a generic antibiotic after black
read more
Therapy indicated for children aged 3 to 14 at treatment initiation More: EC approves Santen’s Ryjunea to slow progression of paediatric myopia Source: News
read more
New funding supports development of diagnostic platform More: Linear Diagnostics awarded £1m to develop rapid STI test Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals